KRW13.03bn Imposed in Fines
The Financial Services Commission fined Celltrion, Celltrion Healthcare and Celltrion Pharm 13.0321 billion won on March 16 for accounting standard violations in financial statements.
The fines on the companies are 6 billion won, 6.04 billion won and 992.1 million won, respectively.
On March 11, the Securities and Futures Commission of the Financial Services Commission advised the three companies to dismiss executives in charge and appoint auditors. “The companies exaggerated their sales and made their business losses look smaller than the actual figures for a long time,” it said at that time.
According to the commission, the amount of Celltrion’s violation in 2016 is 130 billion won and those of Celltrion Healthcare and Celltrion Pharm are 160 billion won and 13 billion won, respectively.